Dr. Rastogi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Meyran Ave
Ste 318
Pittsburgh, PA 15213Phone+1 412-383-1650Fax+1 412-641-1085
Education & Training
- UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2000 - 2003
- Saint Joseph HospitalResidency, Internal Medicine, 1997 - 2000
- Wright State University Boonshoft School of MedicineClass of 1997
Certifications & Licensure
- PA State Medical License 2003 - 2024
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Start of enrollment: 2010 Aug 13
Publications & Presentations
PubMed
- Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial.Priya Rastogi, Hanna Bandos, Peter C Lucas, Laura J van 't Veer, Jia-Perng J Wei
Journal of Clinical Oncology. 2024-10-20 - Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive, Early-Stage Breast Ca...Mariana Chavez-MacGregor, Jieling Miao, Lajos Pusztai, Matthew P Goetz, Priya Rastogi
Journal of Clinical Oncology. 2024-09-01 - 1 citationsLong-term outcomes by lobular versus ductal histology in four NSABP adjuvant breast cancer trials.Julia Foldi, Neil Carleton, Stewart J Anderson, Priya Rastogi, Adrian Lee
Journal of the National Cancer Institute. 2024-08-10
Press Mentions
- Gene Assay for MammaPrint May Predict Responses to Extended Letrozole in Low-Risk Breast Cancer SubsetsAugust 30th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: